Oct 2026
Plasma interleukin-6 levels and treatment responses to antipsychotics in schizophrenia: Focus on clozapine treatment.
Neuroinflammation is a key pathophysiological mechanism underlying treatment-resistant schizophrenia (TRS). Interleukin (IL)-6 is a trait-related biomarker that exhibits consistently elevated levels in schizophrenia. However, studies focusing on TRS and examining the associations of clozapine treatment with inflammator...
Yuhei Suzuki, Kota Endo, Shuuho Yokokawa et al.
· Psychiatry Research · 0 citations